— Know what they know.
Not Investment Advice
Also trades as: ALPMY (OTC) · $vol 2M · ALPMF (OTC) · $vol 0M

4503.T JPX

Astellas Pharma Inc.
1W: -4.8% 1M: -5.3% 3M: +3.2% YTD: -11.3% 1Y: +39.5% 3Y: +20.8% 5Y: +33.8%
¥2,227.50 ($14.09)
-17.50 (-0.78%)
 
Weekly Expected Move ±3.3%
¥2097 ¥2171 ¥2245 ¥2319 ¥2393
JPX · Healthcare · Drug Manufacturers - General · Tech Score Neutral · Power 47 · ¥4.02T mcap · 1.79B float · 0.363% daily turnover

📊 Key Metrics

TTM
¥2,139B
Revenue
+11.9% YoY
¥292B
Net Income
+474.6% YoY
¥509B
Free Cash Flow
+212.0% YoY
75.9%
Gross Margin
14.5%
Op. Margin
8.1%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE17.4%
ROA8.4%
ROIC14.8%

Valuation

P/E10.9
P/B2.1
EV/EBITDA8.1

Leverage

Debt/Equity0.31
Current Ratio1.17
Interest Cov.28.3x

Quality Scores

Piotroski F7/9
Altman Z2.96
Beneish M-2.63

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms